The ZF87/MAZ transcription factor functions as a growth suppressor in fibroblasts.

ZF87/MAZ is a zinc finger transcription factor that activates expression of tissue-specific genes and represses expression of the c-myc proto-oncogene. Infection of NIH3T3 fibroblasts with a retrovirus expressing ZF87/MAZ leads to a significant reduction in G418-resistant colonies, compared to cells infected with a retroviral control. Further, only a small fraction of the G418-resistant colonies express ZF87/MAZ. When the ZF87/MAZ-expressing colonies are expanded, they demonstrate a slow growth phenotype, a delayed transit through G1 phase and a decrease in endogenous c-myc gene expression and cyclin A and cyclin E protein levels. Consistent with a partial G1 arrest, the ZF87/MAZ-expressing cells show a reduced sensitivity to the S phase specific chemotherapeutic agent camptothecin. These data indicate that ZF87/MAZ is a growth suppressor protein in nontransformed cells, in part, by affecting the levels of key cell cycle regulatory proteins.

[1]  G. Strachan,et al.  Transcriptional Repression from the c-myc P2 Promoter by the Zinc Finger Protein ZF87/MAZ* , 1999, The Journal of Biological Chemistry.

[2]  S. Her,et al.  Phenylethanolamine N-Methyltransferase Gene Expression , 1999, The Journal of Biological Chemistry.

[3]  L. Donehower,et al.  Mouse models in tumor suppression , 1998, Oncogene.

[4]  M. Bjornsti,et al.  Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase I* , 1998, The Journal of Biological Chemistry.

[5]  K. Itakura,et al.  Binding of THZif-1, a MAZ-like Zinc Finger Protein to the Nuclease-hypersensitive Element in the Promoter Region of the c-MYC Protooncogene* , 1996, The Journal of Biological Chemistry.

[6]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[7]  K. Itakura,et al.  Members of the MAZ family: a novel cDNA clone for MAZ from human pancreatic islet cells. , 1996, Biochemical and biophysical research communications.

[8]  M. Komatsu,et al.  Specific regulation of gene expression by antisense nucleic acids: a summary of methodologies and associated problems. , 1996, Artificial organs.

[9]  Thomas Shenk,et al.  The Serotonin 1a Receptor Gene Contains a TATA-less Promoter that Responds to MAZ and Sp1 (*) , 1996, The Journal of Biological Chemistry.

[10]  M. Pagano,et al.  Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes. , 1995, The EMBO journal.

[11]  S. Hedrick,et al.  A Myc-associated zinc finger protein binding site is one of four important functional regions in the CD4 promoter , 1995, Molecular and cellular biology.

[12]  D. Hall,et al.  Physical characteristics of a factor related to the c-myc/insulin promoter binding protein ZF87/Pur-1. , 1993, Biochemical and biophysical research communications.

[13]  W. Rutter,et al.  Characterization of a cDNA encoding the insulin gene GAGA-binding factor, Pur-I. , 1993, Biochemical Society transactions.

[14]  W. Rutter,et al.  Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Patel,et al.  MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Moberg,et al.  Isolation of a novel cDNA encoding a zinc-finger protein that binds to two sites within the c-myc promoter. , 1992, Biochemistry.

[17]  J. Martial,et al.  The evolutionarily conserved Krüppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Weinberg,et al.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.

[19]  C. Stiles,et al.  Platelet-derived growth factor-inducible genes respond differentially to at least two distinct intracellular second messengers. , 1987, The Journal of biological chemistry.

[20]  A. Patel,et al.  myc function and regulation. , 1992, Annual review of biochemistry.

[21]  M. Groudine,et al.  Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.

[22]  M. Cole.  The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.